GNB-03

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGNB-03

Drug Alias Nameantibody biosimilar (GlycoNex)GNB-03

ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionBone resorption inhibitors

TargetsUpdating

Therapy Area/IndicationsOsteoporosis, Postmenopausal

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGlyconex Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesGlyconex Inc

Active IndicationsN/A

Inactive IndicationsOsteoporosis, Postmenopausal

ATC CodeN/A